Skip to main content

Table 1 Patients' Demographics.

From: Can local application of Tranexamic acid reduce post-coronary bypass surgery blood loss? A randomized controlled trial

 

TA (n = 19)

Placebo (n = 19)

P-Value

Age (y)

55 ± 11

60 ± 7

0.17

M/F

18/1

18/1

1.0

Wt. (Kg)

73 ± 15

71 ± 14

0.74

BMI

27 ± 4

27 ± 4

1.0

Smoking

6 (31.5%)

6 (31.5%)

1.0

Diabetes

7 (37%)

10 (53%)

0.42

Hypertension

7 (37%)

12 (63%)

0.17

Hyperchol

3 (16%)

0 (0%)

0.08

COPD

1 (5%)

1 (5%)

1.0

RF

0 (0%)

1 (5%)

0.33

PVD

3 (16%)

0 (0%)

0.08

Previous MI

4 (21%)

6 (31.5%)

0.42

LVEF

48 ± 10

46 ± 10

0.49

Euroscore

2.3 ± 1.7

2.5 ± 1.6

0.58

  1. Values are means ± SD or No.(%) where shown.
  2. M/F: Male/Female
  3. Wt.: Weight
  4. BMI: Body Mass Index
  5. COPD: Chronic Obstructive Pulmonary Disease
  6. RF: Renal Failure
  7. Hyperchol: Hypercholesterolmia
  8. PVD: Peripheral Vascular Disease
  9. MI: Myocardial Infarction
  10. LVEF: Left Ventricular Ejection Fraction